ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
AIM ImmunoTech Inc

AIM ImmunoTech Inc (HXB2)

0.208
0.00
( 0.00% )
Updated: 10:39:40
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.208
Bid
0.202
Ask
0.216
Volume
0.00
0.00 Day's Range 0.00
0.178 52 Week Range 0.60
Previous Close
0.208
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
7,660
Financial Volume
-
VWAP
-

HXB2 Latest News

AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer

AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer Preliminary finding of stable disease in two...

AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast

AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast OCALA, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE...

AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®

AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen® OCALA, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”...

AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer

AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer Next safety cohort...

AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer

AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer OCALA...

AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update Year marked by growing body of promising data demonstrating Ampligen’s potential to...

AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast

AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast OCALA, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- AIM...

AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research Data demonstrate...

AIM ImmunoTech Announces Launch of CEO Corner Platform

AIM ImmunoTech Announces Launch of CEO Corner Platform CEO Corner segments to provide added perspective to press releases, corporate developments and pipeline progress Provides interested...

AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update

AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update Company continues progress across Ampligen® clinical development programs Growing...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00840.20.2260.218110.22206184DE
4-0.02-8.771929824560.2280.2320.17881220.20419535DE
12-0.068-24.63768115940.2760.310.17876600.23112459DE
26-0.148-41.57303370790.3560.4360.17850480.25664062DE
52-0.238-53.36322869960.4460.60.17839760.32678636DE
156-0.3569999-63.18583419220.56499990.610.17839260.34563565DE
260-0.3569999-63.18583419220.56499990.610.17839260.34563565DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
Y920Trilogy AI Corp
0.049 €
(75.00%)
1.34k
NL8Genesis Ai Corp
0.0182 €
(51.67%)
2k
VJFVital Metals Ltd
0.0018 €
(50.00%)
550.89k
8C5Coherus Biosciences Inc
1.8485 €
(42.14%)
360.84k
DW8Tantalex Lithium Resources Corp
0.0195 €
(34.48%)
34k
RUOCOcean Power Technologies
0.319 €
(-51.07%)
2.68M
CNWCodon AG
0.0065 €
(-40.91%)
58.53k
TZUTrigon Metals Inc
0.308 €
(-40.19%)
8k
BDDConico Ltd
0.0004 €
(-33.33%)
1.25k
SQHSpearmint Resources Inc
0.0082 €
(-31.67%)
137k
PF8European Lithium Limited
0.0418 €
(33.12%)
9.65M
D7GNel ASA
0.2451 €
(-3.12%)
5.89M
AXIAtos SE
0.4772 €
(-31.36%)
5.09M
RUOCOcean Power Technologies
0.319 €
(-51.07%)
2.68M
REBArafura Rare Earths Ltd
0.0752 €
(-1.05%)
2.14M

Discussion

View Full Feed
jimr1717 jimr1717 1 minute ago
Exactly as predicted. A snow storm and the powerful EM effect on the same day.

Please see my long list of nonsense on this as well as other useless topics.
TSLA
eagpup eagpup 1 minute ago
Your words were “sooner than you think” in regards to nexboard. So explain what your words mean? Was it just a pump. This is my hang up with Xeriant.
XERI
carvajal carvajal 1 minute ago
Just the basic version, I guess we've all been logged out. Let's style="font-size: 1em" see if humbl releases a PR since they haven't said anything yet.
HMBL
Chartmaster Chartmaster 2 minutes ago
AB INTL Group Announces Repurchase of 300 Million Shares and Planning Spin-off of NFT MMM IP and AI Consulting Business

NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today an
ABQQ MMM
TheFinalCD TheFinalCD 2 minutes ago
Thank you, I wish we were neighbors, Id invite you over, my wife is a great cook

you are surely one of the all time nicest persons I met on the hub

Im mostly on @X

God Bless you and your family

really hoping and praying for an awesome 2025
ZJK
dshade dshade 2 minutes ago
thanks for the cheap shares. see enjoy this month. catching a flight! cheers to most of the longs that were relaxed and patient.
CBRF
jay_tee jay_tee 2 minutes ago
Self gratification. Hey whatever gets you through the day. MDA is correct. We have nothing better to do on this board!!!! LOL
RNVA
europa7 europa7 2 minutes ago
Shiba Inu Coin Lead Slams Litecoin As It Changes Identity To Meme Coin
November 19, 2024
https://coingape.com/shiba-inu-coin-lead-slams-litecoin-as-it-changes-identity-to-meme-coin/
SHIBUSD
Whalatane Whalatane 2 minutes ago
ARDX Dew , the work around I described would be an off label script and is currently not being used in the dialysis clinics my wife rounds.
Theres understandable caution because of the liability the physician would face
https://jaapl.org/content/early/2020/11/24/JAAPL.200049-20
ARDX
Rainer Rainer 2 minutes ago
FUNR .0004 +300% on company merger tweet
FUNR
TAB78 TAB78 3 minutes ago
So I am understanding this correctly, that we really don't if any effort is being put forth to re organize the company

CBBT
SPARK'S FLY SPARK'S FLY 3 minutes ago
Let it Run!!! Is there a Buy out? 
SRMX
PennyMillions852 PennyMillions852 3 minutes ago
Agree fully! Folks just hanging around waiting on the miracle name change that may not even affect the PPS! Something else is needed here…this POS been on a tanking spree!!!
IGPK
swingingRichard swingingRichard 3 minutes ago
They usually respond with a "decent" justification. Their targets almost always cry foul. But over time it "feels" like (I'm not doing a historical study right now) they get more right than wrong. But that could be my personal biases. 
Stock_Barber Stock_Barber 3 minutes ago
When one's role is to promote the shares, the only options are deflection and/or completely ignoring all the negatives!

So damn obvious!


https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Fdifitech.id%2Fwp-content%2Fuploads%2F2022%2F06%2Fbeda-paid-promot
DBMM
FeMike FeMike 3 minutes ago
Or like, I’m optimistic that Iclight will tell everyone he is not invested in NWBO, yet he is here all the time talking trash and spreading lies. I hope it happens…but prolly not!

This is an accurate depiction of the word 'optimistic' being used incorrectly in a sentence.
NWBO
ducci1 ducci1 3 minutes ago
Nice Falling Channel 1 min ES & SPX !!--See If They can take it out !
SPY
Dead On Arrival Dead On Arrival 4 minutes ago
Why you engage that they/them poster is beyond me. He is as creepy as Marcelli.
LWLG
Myth Myth 4 minutes ago
Giving It All Away - Roger Daltrey

https://www.youtube.com/watch?v=k8OBH2C5d-c
LIVE
https://www.youtube.com/watch?v=gck-lFLsI1I
powerwalker powerwalker 4 minutes ago
george, isn't Anavex presenting at a Noble investors' meeting this week?
AVXL
BlazingStocks BlazingStocks 4 minutes ago
$ILLR - The app is poised to transform the digital realm for content creators, enthusiasts, and businesses. Following the recent announcement of Sean Kim, former Head of Product at TikTok, as the new Chief Executive Officer of Triller App and the Company’s Triller Platform Co. subsidiary, the compan
ILLR
Rdizz23 Rdizz23 4 minutes ago
Joe stern is a nobody, he has zero credentials on his LinkedIn to run an entire division and animal health at that.
ALRTF
Sirius_Corona Sirius_Corona 4 minutes ago
It hurts me deeply to see so many here loss everything. I come back to this board yearly hoping for a glimmer of hope and sign from Stacey and management they are righting wrongs to no avail. Inca was a real business with real products and a lot of potential, but clearly management did not want to d